For press inquiries click here to contact us.
The Boston Globe
Intarcia seeks approval of drug-device combo to treat Type 2 diabtes
Fortune
A New Innovation for Type 2 Diabetes
Bloomberg
Nestle Pays $145 Million for Stake in Biotech Firm Aimmune
Reuters
AstraZeneca licenses respiratory drug to Insmed
FierceBiotech
FierceBiotech’s Fierce 15 for 2016: Arcus Biosciences
StreetInsider.com
Epizyme (EPZM) Announces Earning $6M Milestone Related to GSK3326595 Phase 1
Fortune
Diabetes ‘Unicorn’ Raises Final VC Round Before IPO
StreetInsider.com
Aerie Pharma (AERI) PT Raised to $52 at Needham & Company as Roclatan Knocks It Out of the Park
The Boston Globe
Boston Biotech Intarcia Raises Major Funding for Type 2 Diabetes Treatment
Please see important disclaimers in the Terms section.
